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Introduction 
Cardiovascular disease is the leading cause of death in Hungary. The standardized death rate for 
circulation disease is 779.4 deaths per 100 000 inhabitants, which is the 6th worst data in the 
European statistics. The data is even worse in case of ischemic heart disease.  In case of ischemic 
heart disease the standardized death rate is 400.1  deaths per 100 000 inhabitants, which is a weak 
data as compared to the average standardized death rate in Europe which is 137 deaths per 100 000 
inhabitants. 
The most common cause of the cardiovascular disease is the arteriosclerosis and within this broader 
category the atherosclerosis. Atherosclerosis is a progressive disease and only some of its risk factors 
are modifiable or can be eliminated.  The primary prevention has a high significance in the outcome 
of the disease.  Therefore the early diagnose of atherosclerosis and those non-invasively determined 
biomarkers, which can improve the personal risk stratification, are come into prominence.  
The early diagnose of atherosclerosis is part of the cardiovascular primary prevention. The screening 
covers epidemiological risk stratification, physical examinations, laboratory tests, and some non-
invasive scanners and methods are in used. The most important non-invasive methods are the B-
mode ultrasound examination of the vessel wall, the different measurements of stiffness parameters 
and the evaluation of Agatston score in non-contrast enhanced CT images. 
 
1. Determination of normal β values via radio frequency echo-
Tracking technique 
Nowadays there are many different devices with different technical background available on the 
market for the evaluation of vascular stiffness.  Most of these equipments determinate the changes 
of vascular stiffness based on the measurement of PWV and AI value. With RF echo-Tracking, besides 
these two parameters, the β stiffness parameter and pressure-strain elasticity modulus (Ep) and 
arterial compliance (AC) value are determined.  These three parameters are calculated from the 
blood pressure and the diameter changes of the vessel (Table 1.).  The Ep and AC values strongly 
depend on blood pressure because the diameter-pressure relationship is non-linear. The β stiffness 
value is less blood pressure dependent because of its calculation method. And it is blood pressure 
independent in case of normotension.  
1.1. Objectives 
To the best of our knowledge, our team is the first that determined normal values of β stiffness 
parameter and PWV via RF echo-Tracking in a healthy Central European population during the years 
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2005 and 2006. The PWV parameter was chosen, because it is an accepted independent predictive 
factor in the risk assessment of atherosclerosis with an ascertained cut off value, which was 
determined with other methods of stiffness measurements.  The β stiffness was examined because it 
is less blood pressure dependent than the other stiffness parameters, and we found no normal 
values of β stiffness parameter in European population in the literature.  One of our cases (discussed 
in the next section) had been suggested that the determination of normal β value in different age 
groups in both genders was necessary in domestic population for the appropriate clinical application 
of the method, because our findings were showed that there might be a significant difference in 
normal values of healthy Asian and health European population. 
1/a. 
Ep (pressure-strain elasticity modulus): representing the arterial stiffness 
Ep = (Ps-Pd)/[(Ds-Dd)/Dd] 
 
β (stiffness parameter): representing the arterial stiffness 
β = In(Ps-Pd)/[(Ds-Dd)/Dd] 
Blood pressure dependency is lower than that of Ep. 
 
AC (arterial compliance): representing vessel compliance 
AC = π(Ds×Ds-Dd×Dd)/[4(Ps-Pd)] 
 
1/b. 
AI: augmentation index 
PWV: pulse wave velocity 
 
Table 1. Parameters are representing properties of vessel wall and are calculated automatically by the E-Tracking 
software.  1/a. These parameters are calculated from systolic and diastolic blood pressure values and from the systolic 
and diastolic diameters of the examined vessel 1/b. These parameters are automatically calculated by the analysis of the 
detected sphygmogram. 
 
1.2. Methods 
For the measurement of stiffness parameters ALOKA USV 5410 ultrasound equipment with linear 
transducer (3-10 MHz) and with special software for the RF e-Tracking option had been used. To 
standardize the measurement the examinations were performed by two experts at the same time of 
the day, in the same air-conditioned room after 5-10 minutes of rest.  
1.3. Patient population 
Our team examined all together 146 volunteers of different age groups between 3 and 65 years in 
both sex (male n=51, female n=95). These volunteers had no remarkable changes in their laboratory 
findings, their body mass index (BMI) were in normal range and had not got any modifiable risk 
factors of vascular and cardiovascular diseases. We exclude those volunteers who had high blood 
pressure (140/90 mmHg<) or abnormal IMT (0.8mm <) on site. 
1.4. Results 
We analyzed the PWV and β stiffness parameters in five different age groups (≤25 ys, 26-35 ys, 36-45 
ys, 46-55 ys and 56-65 ys) in both genders.  We found that the values of β stiffness parameter and 
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PWV show slightly elevation during the aging in both genders (Table 2, Fig. 1).  The intraobserver 
coefficient of variation was 6.9% for β-stiffness and 3.5% for PWV. The interobserver coefficient of 
variation was 8.8% for β-stiffness and 4.6% for PWV. 
    
 
Table 2. The normal values of β stiffness and PWV parameters were determined via RF echo-tracking method. 146 
healthy volunteers (51 males and 95 females, 3 - 65 year-olds) were examined in five different age groups. Data are 
presented as mean ± SD (standard deviation). Mean and SD of blood pressure (BP) and heart (HR) for each age groups 
were calculated as well. 
 
Figure 1. Diagrams show that normal values of β and PWV parameters slightly increase with aging  
 
1.5. Conclusions 
Results of intra- and interobserver studies show that RF e-Tracking technique is a reliable and 
reproducible method of vascular stiffness measurement. One of the obtained parameters was the β 
stiffness parameter. In case of normotensive population this parameter is non-blood pressure 
dependent unlike PWV and AI with, therefore it may show stronger correlation with the rigidity of 
the vessel wall.  Based on our data the vascular stiffness slightly increases with aging in both sexes. 
One of the possible explanations is that the healthy population had a clinically non manifest or early 
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form of atherosclerosis which means that there are no non-invasively visible changes on the arterial 
wall. The other interpretation can be the relative or absolute decreasing of elastic vascular 
components during the normal aging. The invasive, histological examination was not part of our 
investigation; therefore we cannot tell which idea is correct. 
 
2. Clinical application of RF e-Tracking in case of a patient with 
progeria 
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare genetic condition. The reported 
incidence is 1:8 million, estimated incidence is about 1:4 million since the first cases were reported in 
1898 by Hutchinson and in 1902 by Gilford.  The reason of this disease was unknown until 2003, 
when a de novo point mutation in the lamin A gene had been determined as the most common 
reason. This gene encodes a protein that helps to maintain the structural integrity of the cell nucleus. 
Patients with this disorder suffer from symptoms of accelerated aging, such as thin and wrinkled skin, 
hair loss, osteoporosis and most notably vascular disease (atherosclerosis). Appearance and 
progression of vascular disease determinates the quality and the term of their life. Atherosclerosis 
causes stroke and/or myocardial infarction during its progression which leads to death of these 
patients by the end of their second decade of life. Early diagnosis and treatment of atherosclerosis 
may increase therapy effectiveness. 
Our patient was a 9-year-old male. In his case the progeria syndrome was diagnosed in the first year 
of his life.  The genetic abnormality was determined at the age of 9. He had some symptoms of 
premature aging.  His mental development was normal and he had no signs or symptoms of vascular 
disease. Laboratory, ECG, echocardiography, carotid arteries B- and duplex-scan findings were 
unremarkable. His blood pressure was within the normal range. The aim of our ultrasound 
examination was to determinate the vascular age of the patient and diagnose the early stage of 
atherosclerosis if it was present. 
The appearance of the common carotid arteries was normal on B-scan and there were no detectable 
sings of any stenosis by using duplex Doppler technique. Our examination revealed a blood-pressure 
of 111/69 mmHg, a 5.19 mm maximal and 4.97 mm minimal vessel diameter on the left side, and a 
6.20 mm maximal and 5.94 mm minimal vessel diameter on the right side. The measured β values 
were 10.8 in case of the left, and 11.0 in case of the right CCA, which corresponds to the 36-45-year-
old healthy population group and suggests an early stage of atherosclerosis. Our patient’s β value 
was threefold higher compared to his own age: our data (Fig. 2, 3) suggests that under the age of 15, 
the normal β value is 3.46 ± 0.71 (n=7). 
Regarding our data we have demonstrated that our patient biological age was significantly higher 
than his chronological age.  Compare his stiffness parameters to the normal values of an Asian 
population his biological age was 45 years. Compare to our normal values of a domestic population 
his biological age was even higher. It was more than the determined highest normal value which can 
be explained by the presence of early stage of atherosclerosis.  Though the measured PWV β (6.9 
m/s) did not reach the widely accepted cut off value (10 m/s) of the PWV it was quite close. 
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Figure 2 Original registrant of the measurement in case of the left common carotid artery of a 9 year-old child with 
progeria syndrome   
 
 
Figure 3 Patient’s main β value was more than threefold higher than the normal of his own age group: under age 15 the 
normal β is 3.46 ± 0.71 (n=7). 
 
3. Evaluation of epicardial fat volume, Agatston-score and stiffness 
parameters in patients with CAD  
In the first decade of the 21st century epicardial fat volume (EFV), besides the Agatston-score and the 
stiffness parameters, has come to the fore in the risk assessment of CAD. EFV can be easily measured 
by a semi-automatic software in the non-contrast enhanced cardiac CT images, which were 
reconstructed for the evaluation of Agatston score (coronary artery calcium score (CACS)). The larger 
volume of epicardial fat results in increased coronary artery disease (CAD) risk because in case of 
higher epicardial fat volume (EFV) the atherogenic factors of the epicardial fat become predominant.   
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3.1. Objectives 
The aim of our study was to find connections between EFV, Agatston- score and the stiffness 
parameters (measured with Arteriograph) in patients with known CAD. Most of our patient 
underwent coronary CT angiography (CCTA) examination too. In this group of patients the 
connections between the severity of CAD and the EFV and the stiffness parameters were examined 
as well. 
3.2. Methods  
For CT imaging 64 slice dual-source CT (Somatom Definition;  Siemens Medical Solutions, Forchheim, 
Germany)  scanner with ECG dependent tube current modulation (Care Dose 4D) had been used with 
0.33 s of rotation time. Depending on the patient’s heart rate prospective ECG-triggering (HR <60 
bpm) or retrospective ECG-gating (HR > 60 bpm or arrhythmia) was applied. Pharmacologic heart 
rate modulation was necessary with administration of β-blocker (metoprolol orally [50 mg] or 
intravenously [5-10 mg]) when the patient’s heart rate was higher than 95 bpm before scanning. 
Orally nitroglycerin (0.8 mg) was also administered before the CT imaging procedure.   
Non-contrast and contrast enhanced images were acquired between the level of tracheal bifurcation 
and the diaphragm during a single breath-hold. Following a native scan contrast enhanced image 
acquisition was performed by using bolus tracking technique. In all cases we used iomeprol intra 
venous contrast material with 350 mg/mL iodine content.  
Native scan’s data sets were reconstructed with B35f convolution kernel, 3 mm effective slice 
thickness and 1.5 mm increment for calcium score measurements.  Contrast enhanced data sets 
were reconstructed with B26f convolution kernel, 0.75 mm effective slice thickness and 0.4 mm 
increment for quantitative coronary analysis. All of these reconstructions were performed in 
overlapping mode. The reconstruction window was at 70% of the cardiac cycle in case of prospective 
ECG triggering. In case of retrospective ECG gating the reconstruction window was depend on heart 
rate. To quantify the calcium content of coronary arteries the Agatston scoring method had been 
used. The software tool (Syngo CAC, Siemens Medical Solutions, Forcheim, Germany) automatically 
marked out every contiguous three pixels with a density of above 130 HU.  Those marks which cover 
coronary arteries (RCA, LM, LAD and Cx) were selected manually. Than the software tool calculated 
the score by multiplying the area of the marked lesion by a density factor obtained from the 
maximum HU in the lesion. Total calcium score is the sum of individual lesion scores. For the 
measurement of epicardial fat volume axial slices of non-contrast enhanced MDCT images were 
analyzed.  In our definition epicardial fat is the adipose tissue which is situated between the visceral 
layer of pericardium and the myocardium. The pericardium was traced semi automatically in 3D by a 
dedicated software tool (Syngo Volume, Siemens Medical Solutions, Forchheim, Germany) between 
the level of the pulmonary trunk's bifurcation and the diaphragm. Manual optimization of the 
pericardial borders in multiple planes was performed if it was necessary.  To separate fat from other 
tissues in the region of interest enclosed by the pericardium thresholds of -30 to -190 HU were 
chosen. The total volume of epicardial fat was reported in cm3 at the end of the measurement. 
For the analysis of coronary CT angiogram another dedicated (Syngo Circulation, Siemens Medical 
Solutions, Forchheim, Germany) software had been used. The threshold of significant area stenosis 
was 75%. 
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Regional stiffness parameters had been measured in standard conditions with arteriograph 
(Arteriograph, TensioMed, Budapest, Hungary) right before the CT examination. With a short 
compression and fast decompression of the brachial artery the pulse wave was registered 
oscillometric. The PWV and AI were calculated by the analysis of the nicely separated anterograde 
and the retrograde waves and with the measurement of the distance between pubic symphysis and 
jugular notch.   
 
3.3. Patient population 
To find relationship between arterial stiffness parameters, Agatston score and EFV 158 consecutive 
outpatients who had been referred for cardiac CT and simultaneously underwent both cardiac CT 
examination and oscillometric pulse wave analysis were enrolled.  Among these patients there were 
111 who underwent CCTA as well. Thus the examination of connections between the EFV, stiffness 
parameters and the degree of the coronary artery stenosis became possible. A written informed 
consent was signed by each of the enrolled patients. 
 
3.4. Results 
As for the stiffness parameters, both AIx and PWVao were significantly higher (p≤0.01) in CAD patient 
group than in the control group. In the CAD patient group the average value of AIx was 34.5 ± 14.7% 
and the average value of the PWVao was 10.2 ± 2.3 m/s. In case of healthy population the average 
value was 30.2 ± 12.8% for AIx and it was 9.5 ± 1.6 m/s for PWVao (based on former data of work-
group).  Compared our examined parameters (AIx, PWVao, EFV and Agatston score) we found 
significant differences between average values of EFV and Agatston score of the CAD and the control 
group(p≤0.01). EFV value was 121.1 ± 69.8 cm3 in CAD patient group and it was 83.7 ± 39.3 cm3 in the 
control group. The mean value of the Agatston score was 207 (0-1327) in CAD patient group and 5.3 
(0-146) in the control group. 
The mean value of Agatston score was significantly higher (p<0.05) in both male (424.27) and female 
(94.39) patients group with coronary stenosis. The highest mean values were measured in the 
patient groups (male: 1002.35, female: 605.5) with significant coronary artery stenosis. 
Normal mean values of EFV were detected in case of patient group without coronary artery stenosis 
in both sex (male: 98.16 cm3, female: 76.04 cm3), and the highest mean values were found in the 
patient group with significant coronary artery stenosis in both sex (male: 152.35 cm3, female: 100.78 
cm3). But the data of male patients alone showed a significant difference in this respect.  
 
3.5. Conclusions 
Our results suggest that the Agatston score and EFV measured with semiautomatic software in 
appropriately reconstructed cardiac CT images and the oscillometric detected stiffness parameters 
are important biomarkers of CAD, because all of these parameters were significantly higher in CAD 
patient group compared to the control group.  There were significantly higher Agatston score and in 
case of male patients significantly higher - and based on literature abnormal - EFV in case of the 
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patient group with significant coronary artery stenosis. Though in case of female patients we did not 
found significant connection between EFV and severe coronary artery stenosis and the mean value of 
EFV was lower than the abnormal, but it might caused by the low number of patients. 
Our results showed weak correlation between EFV and Agatston score which suggests that these 
parameters might be independent predictive parameters of CAD. It is possible that the different 
dominant risk factors of CAD can bias different examined parameters. But because of the relatively 
low number of the enrolled patients we had no chance to subdivide the patient groups into further 
distinct groups based on the dominant risk factors.  In a subsequent study we examined whether one 
of the major CAD risk factor - the type 2 diabetes mellitus - has any effect on the EFV and Agatston 
score values. 
 
4. Evaluation of epicardial fat volume, Agatston-score, BMI and hepatic 
density values in patients with type 2 diabetes mellitus 
4.1. Objectives 
Based on the literature our research group was the first who studied the relationship between BMI, 
Agatston score, EFV and hepatic density in type 2 diabetic patient group and control group in 
domestic population by a retrospective, cross-sectional correlation  analysis. 
4.2. Methods 
For cardiac imaging 64 slice DSCT scanner (Somatom Definition; Siemens Medical Solutions, 
Forchheim, Germany) had been used. We analyzed appropriately reconstructed non contrast images 
for the evaluation of Agatston score and EFV as described above. And hepatic density in Hounsfield 
units (HU) had been measured in the same reconstructed non contrast images with the same size 
and shape of ROI (region of interest) at level of 8th hepatic segment. The mean density of healthy 
liver is 50-70 HU. In case of diffuse hepatic steatosis the mean density of the liver is less than 40 HU. 
Body mass index (BMI) had been calculated as body weight in kilograms divided by body height in 
meter squared. 
4.3. Patient population 
In this clinical study 158 (73 male and 85 female) of our patients, who underwent cardiac CT 
examination in 2014 - 2015, were enrolled. These patients were referred for cardiac CT examination 
either to assessment of CAD or planning and guiding of catheter ablation therapy with 3D 
reconstructions. In our patient population two patient groups, type 2 diabetic patient group (n=60, 
male: 30, female: 30) and control group (n=98, male: 43, female: 55), were formed. 
4.4. Results 
Comparing the diabetic and non-diabetic patient group the mean value of EFV was appreciably 
higher in diabetic (180.2±69.7 cm3) than in non-diabetic patient group (140.1±65.1 cm3). The mean 
of Agatston score was also remarkably higher in diabetic patient group (383.8±915.8) than in the 
control group (149±33.3). The mean value of hepatic density was lower in diabetic patient group 
(47.2±14.3 HU) compared with the control group (50.8±15.28 HU). The mean of BMI was higher than 
the normal both in diabetic (31.2±5.34) and non-diabetic (28.2±5.18) patient group (Table 3.) Gender 
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comparison showed that the mean of BMI, EFV and Agatston score values are higher and the mean 
hepatic density value is lower in diabetic than in non-diabetic patient group in both genders. 
 Type 2 diabetes Control 
Age (years) 62±9.5 60.16±11.8 
BMI (kg/m2) 31.2±5.34 28.2±5.18 
Agatston score 381.8±915.8 149±33.3 
EFV (m³) 180.2±69.7 140.1±65.1 
Hepatic density  (HU) 47.2±14.3 50.8±15.28 
Table 1  Mean values with standard deviations of age, BMI, Agatston score, EFV and hepatic density in type 2 diabetic 
patient group (n=60) and control, non-diabetic patient group (n=98) 
Based on the results of two-sample T test in case of EFV there is a significant difference (p<0.001) 
between the mean values of the two patient groups. As for the hepatic density mean values there is 
no significant difference (p=0.140) between the patient groups. Statistical analysis with Mann-
Whitney test showed a significant difference (p=0.038) between the mean values of Agatston score 
of diabetic and non-diabetic patient group. Separating according to genders there was significant 
difference (p=0.001) between the male diabetic and non-diabetic patient group’s mean Agatston 
score values. But there were no significant differences between the gender groups in case of other 
examined parameters.  
In our correlation study BMI and age were independent variables, EFV, hepatic density and Agatston 
score were dependent variables. With linear regression analysis we found a statistically significant 
(p<0.001) strong moderate linear correlation between EFV and BMI (r=0.569) and between EFV and 
age (r=0.465) in case of the control group. In case of diabetic patent group a significant (p=0.001) 
weak (r=0.385) correlation was found between EFV and BMI. But there was no correlation between 
the age and BMI (p=0.110). There were a negative significant weak correlation between hepatic 
density and BMI both in diabetic (p=0.012, r=-0.298) and non-diabetic (p<0.001, r=-0.337) patient 
group. There was a non-significant linear correlation (p=0.314) between the hepatic density and age 
in the control group. In case of the diabetic patient group there was a weak (r=0.232), significant 
(p=0.040) linear correlation. With Spearman’s correlation in case of control group there were weak 
significant correlations between the Agatston score and BMI (r=0.183, p=0.040) and between the 
Agatston score and EFV (r=0.323, p=0.001). Between the Agatston score and age there was a strong 
moderate (r=0.440) significant (p<0.001) correlation.  In case of the diabetic patient group there 
were no statistically significant correlations between the Agatston score and BMI (p=0.258) and 
between Agatston score and EFV (p=0.099). However there was a weak (r=0.297) significant (0.011) 
correlation between Agatston score and age. 
 
4.5. Conclusions 
Based on the statistical analysis we came to the conclusion that BMI has a stronger influence on EFV 
than the age, and the higher the BMI the lower the hepatic density both in diabetic and control 
group. The diabetic patient group has a lower hepatic density and a higher EFV than the other group.  
These statistical findings support our idea that with the adequate analysis of non-contrast cardiac CT 
images we can demonstrate the accumulation of ectopic fat (intrahepatic and epicardial fat) on 
account of obesity in diabetic patients.  Agatston score increases with aging in diabetic and non-
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diabetic patient group as well. In case of diabetic patients the calcium content of the coronary artery 
is higher. This suggests that increased EFV promotes changes of the perivascular milieu of the 
coronary arteries and the proinflammatory, atherogenic biochemical and enzymatic agents become 
dominant.  
Interestingly in case of the non-diabetic patient group the EFV and Agatston score are paralelly 
changing parameters, but in case of the diabetic patient group it is not so.  One of the possible 
reasons of that can be the relatively small number of enrolled patients and a large standard 
deviation.  The other explanation is the well-known fact that in the early phase of diabetes the 
microangiopathy is the dominant vascular change.  Later on the macrovascular changes become 
typical with climbing calcium content in the wall of the large and medium sized arteries including 
coronary arteries which results in increasing Agatston score values. But at this point unfortunately 
our study has certain limitations: We had no chance to exam duration of diabetes. The type or length 
of the applied pharmaceutical therapy had not been analyzed yet, neither in diabetic nor in non-
diabetic patients group.  Most of the type 2 diabetic patients have elevated blood lipid levels and 
because of elevated LDL cholesterol and triglyceride levels therefore in this patient group statin 
therapy is widely used.  The statins can stabilize the vulnerable plaques while they may increase the 
calcium content of the vessel wall. Statins may have positive impact on hepatic steatosis.  
 
5. Application of ECG gated angiography in planning and guiding of 
therapeutic procedures based on a case study of a catheter ablation of 
a cardiac arrhythmia  
In our clinical practice the most common indication of cardiac CT examination is coronary artery 
imaging, however there are other indications. The multiplanar or 3D reconstructed images of an ECG 
gated CT angiography can assist in planning and guiding of several catheter and surgical therapies 
(e.g.: catheter ablation of cardiac arrhythmias, TAVI procedures, coronary stent placement, and 
surgery of aortic or left ventricle aneurysms) alone and by 3D printing or by hybrid imaging as well.   
From the examples above imaging prior to catheter ablation of arrhythmogenic foci is the most 
common indication. Merging of the activation map and the 3D CT image and the real time 
intracardiac echocardiogram (ICE) of the left atrium helps to localize and to visualize continuously the 
arrhythmogenic foci during the ablation procedures.  In the case of ventricular arrhythmias arising 
from the left ventricle outflow track 3D electro-anatomy mapping is a highly important option as it 
was confirmed by the following case-study.   
A 54-year-old female patient was hospitalized with 2 years history of premature ventricular 
complexes (PVC) and clinical symptoms of dyspnea and tachycardia and palpitation. Her main 
complaints were palpitations, and occasional dyspnea, enhanced by physical exercise. Premature 
ventricular complexes on surface ECG showed that PVCs had LVOT origin. With stress testing PVCs in 
bigeminal fashion and a 3 sec non-sustained ventricular tachycardia were observed. 
Echocardiography showed concentric left ventricular hypertrophy, moderate diffuse hypokinesis and 
an ejection fraction of 43%.  Previous medications had not provided any symptomatic improvement 
therefore catheter ablation therapy of arrhythmogenic foci became the promising option.  
 
11 
 
Retrospective ECG gated, contrast-enhanced cardiac CT was performed with 64 slice DSCT (Somatom 
Definition; Siemens Medical Solutions, Forchheim, Germany) a week before ablation. There were two 
purposes of the CT examination. One of them was to rule out CAD as a reason of arrhythmia. The 
other was the imaging of the left ventricle, the aortic root and the coronary ostia all together for the 
complex electro-anatomy mapping during the ablation to prevent some complications e.g. narrowing 
or occlusion of coronary ostia. The CT image reconstruction for the evaluation of coronary arteries 
and coronary analysis were performed as subscribed above (Syngo Circulation, Siemens Medical 
Solutions, Forchheim, Germany).  The CT image reconstruction for the evaluation of coronary arteries 
and coronary analysis were performed as subscribed above (Syngo Circulation, Siemens Medical 
Solutions, Forchheim, Germay).  It revealed slight calcification in the left main coronary artery and in 
the left anterior descending artery.  Three-dimensional (3D) electro-anatomical reconstructions of 
the left ventricle CartoSound system (Biosense Webster, Inc, Diamond Bar, CA, USA) had been used.  
This system automatically makes the segmentation of the left ventricle, the aorta and the coronary 
arteries from the reconstructed CT images.  An intracardiac echocardiography catheter (ICE, Sound 
Star) was inserted into the right atrium via femoral venous approach. The endocardial contours of 
the left ventricle, the aortic root, and the right coronary artery were traced on the ICE images at the 
time of the onset of the QRS, and merged with the 3D reconstructed CT image. With electro-
anatomic mapping, the source of PVCs was identified, which was located in the left sinus of Valsalva, 
18 mm below the left main coronary orificium. With continuous ICE visualization of the ablation 
catheter (Navistar) a sufficient RF ablation (30W, 1 min, 50°C) was performed. At the end of the 
procedure programmed stimulation could not trigger PVCs.   
This case demonstrates the advantages of using data sets of cardiac CT during catheter ablation 
procedures. The hybrid imaging provides the opportunity of a safe and effective catheter ablation of 
the left ventricle outflow track arrhythmogenic foci which could not be possible with ICE guiding 
alone. 
 
Summary 
In my clinical research I studied ultrasonic, oscollometric and computed tomography biomarkers of 
atherosclerosis.  
Initially I stated to work with RF echo-Tracking method, which was a new technical tool for detection 
vascular stiffness parameters. These parameters seemed to be useful data in diagnosis of early stage 
atherosclerosis. We tested the reliability of this method at first. Than our research group was the first 
to determinate the normal values of the less blood pressure dependent β stiffness parameter in 
different age groups of healthy volunteers in both genders with this method in Central European 
population. As a control the PWV value was also measured in the same groups. As we expected the 
mean values of both parameters were slightly increasing with aging. A possible clinical application of 
this method was demonstrated and the prognostic value of stiffness parameters was emphasized in a 
case report of a patient with progeria syndrome. 
 
In our following research besides the stiffness parameters Agatston score and epicardial fat volume 
(EFV) were studied first in a Hungarian CAD patient group and control group. In this study stiffness 
parameters (AIx and PWVao) were oscillometric measured and Agatston score and EFV values were 
collected with the evaluation of cardiac CT images. All of these parameters were higher in CAD 
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patient group than in control group and they are important markers of atherosclerosis. We found 
weak or no correlation between these parameters. It has been suggested that these parameters have 
independent predictive value and the different back ground of the CAD might be important. The 
different dominant risk factors could be the reason of the unequal increase of the studied 
parameters in CAD patient group. 
In our further research we studied the Agatston score, EFV, hepatic density and BMI values in type 2 
diabetic patient groups, again firstly in domestic population. Based on our results the measurement 
of these parameters during the analysis of native cardiac CT images can improve the personal risk 
assessment of CAD in type 2 diabetic patients without further examinations or further radiation 
exposure.  
And finally we demonstrated the effectiveness and advantages of hybrid imaging in cardiac catheter 
ablation therapies of arrhythmias and showed the function of merged cardiac CT images in 3D 
electro-anatomic mapping with a case report. ECG gated CT examinations provide further 
opportunities for planning and guiding of catheter and surgical procedures. Beyond catheter ablation 
of arrhythmias, the 3D imaging of the aorta and the heart is crucial in TAVI (transcatheter aortic valve 
implantation) procedure and in morphological correction of cardiac chambers.  Moreover 3D printing 
of these structures is became possible with ECG gated CT imaging. 
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Novel findings 
In Central European region firstly we determinate the normal values of PWV and β stiffness 
parameter with RF echo-Tracking technic. We also studied the intra- and inter observer reliability of 
this method. And with the publication of a case-report of a patient with progeria syndrome a special 
clinical application of RF echo-Tracking method was presented. 
 
We were first to study the connections between stiffness parameters and Agatston score and 
EFV together in CAD patient group. 
 
Also we were first to study the connection between Agatston score, EFV, hepatic density and 
BMI parameters in type 2 diabetic patients in Hungary. 
 
We demonstrated the important role of cardiac CT examination and hybrid imaging in 
catheter ablation therapy of cardiac arrhythmias with a case-report. 
  
 
14 
 
 
Author’s publications 
1. Original publications related to the thesis 
Várady E, Fehér E, Markó L, Battyáni I: Determination of normal ß values via radiofrequency echo-
tracking technique in healthy Central European population Clinical Hemorheology and 
Microcirculation 2014 (57) 185–189. (IF: 2.242) 
Maurovich-Horvat P, Bratykowszki A, Kerecsen G, Thury A, Károlyi M, Balázs G, Várady E, Tóth L, 
Pintér N, Szukits S, Kolozsvári R, Hoffer K, Király I, Nagy L, Hüttl K, Préda I, Palkó A, Kiss RG, Battyány I, 
Merkely B: A koronária-CT-angiográfia leletezése Cardiologia Hungarica 2013;43 (5): 275-281 
Várady E, Fehér E, Lévai A, Battyány I: Estimation of vessel age and early diagnose of atherosclerosis 
in progeria syndrome by using echo-tracking Clinical Hemorheology and Microcirculation 2010;44(4) 
1-5 (IF: 2.838) 
Rausch P, Manfai B, Varady E, Simor T: Radiofrequency catheter ablation of left ventricular outflow 
tract tachycardia with the assistance of the CartoSound system. Europace. 2009 Sep;11(9):1248-9. 
(IF: 1.871) 
Várady E, Fehér E, Battyány I: e-Tracking a klinikai gyakorlatba – Az érfalkárosodás korai 
diagnosztikája IME (Az egészségügyi vezetők szaklapja) 2007; VI (nov.): 28-31. 
 
2. Abstracts related to the thesis 
Várady E, Szukits S, Dezső D, Tóth L, Bogner P, Battyáni I, Bódis B: Nem kontrasztanyagos szív CT 
vizsgálattal nyerhető, egyéni cardiovasculáris rizikót befolyásoló adatok vizsgálata 2-es típusú 
diabeteses betegeknél. Magyar Radiológia 2016;90 suppl 1: 134-5. 
Tóth L, Szukits S, Várady E, Bogner P: Komplex kardiovasculáris vizsgálat DSCT-vel. Magyar Radiológia 
2016;90 suppl 1: 133. 
Gaszner B, Varady E, Lenkey Z, Husznai R, Gratz S, Galambos A, Cziráki A, Szabados S:   Comparsion of 
arterial stiffness parameters, epicardial fat volume and coronary calcium score in patients with 
coronary artery disease. European Heart Journal 2013;34 suppl 1 P 1577: 309. 
Rausch P, Mánfai B, Ruzsics B, Várady E, Szukits S, Simor T: CARTO-Sound rendszerben végzett Image 
integráció előnyei LVOT ablációja során. Cardiologia Hungarica 2009; 39: G8 
Várady E, Fehér E, Stefanics O, Battyáni I: Vascular age determination. Magyar Radiológia 2006; 80 
(5-6): 219 
Fehér E, Várady E, Kovács T, Késői I, Stefanics O, Battyáni I: E-tracking: a new ultrasound method in 
examination of early atherosclerosis. Magyar Radiológia 2006; 80 (5-6): 195- 196. 
 
15 
 
3. Further publications and abstracts 
Battyány I, Dérczy K, Csete M, Várady E, Harmat Z, Lévai A: XXI. századi csúcstechnológia a PTE 
Térségi Szűrő és Diagnosztikai Központjában (TSZDK) IME (Az egészségügyi vezetők szaklapja) 
2007;6(6):42-44. 
Lénárd L, Szabados S, Imre J, Pintér Ö, Fazekas A, Tornai Z, Dérczy K, Várady E, Papp L: Vena cava 
superior szindróma: dializáló katéter okozta vena cava superior trombózis sebészi kezelése – Irodalmi 
összefoglaló egy esetünk kapcsán Orvosi Hetilap 2008; 149 (1): 29-34. 
Szabados S, Varady E, Göbölös L: Luetic mycotic pseudoaneurysm of the aortic isthmus  Eur Heart J. 
2009 Aug;30(16):1963.  
Szabados S, Varady E, Göbölös: Cardiovascular flashlight. Paraganglioma of the aortopulmonary 
window.Eur Heart J. 2009 May;30(10):1286.  
Weninger C, Csete M, Dérczy K, Szukits S, Várady E, Battyáni I: Kettős energiájú képalkotás CT-vel, CT 
vizsgálat két röntgencsővel Magyar Radiológia 2010;84(1).  
Lévai A, Várady E, Szukits S, Weninger C, Battyány I, Illés T: A scoliosis műtéti kezelése, valamint pre- 
és posztoperatív nyomon követése EOS teljesteströntgennel Magyar Radiológia - 2010;84(4) 234. 
Szabados S, Lénárd L, Tornóczky T, Várady E, Verzár Z:  Ectopic pancreas tissue appearing in a 
mediastinal cyst Journal of Cardiothoracic Surgery 2012, 7:22 
Várady E, Szukits S, Simor T, Battyány I: Fokozódó diszpnoe ritka kóreredettel – esetismertetés IME 
2012; XI (7): 33-35. 
Toth A, Szukits S, Varady E, Sandor B, Rabai M, Papp J, Juricskay I, Kesmarky G, Toth K, Sumegi B, 
Battyani I: Hemorheological parameters in coronary artery disease detected by multi-slice CT Korea-
Australia Rheology Journal 2014;26 (2): 229-235 
Lénárd L, Szabados S, Imre J, Pintér Ö, Fazekas A, Tornai Z, Várady E, Papp L: Tesio dialisáló katéter 
okozta vena cava superior trombózis sebészi kezelése – Eset ismertetés. Cardiologia Hungarica 2006; 
36:6. 
Várady E, Lénárd L, Bozó J, Czopf L, Szabados E, Szukits S, Hernádi G, Simor T, Péterfi Z, Battyáni I: Szív 
CT vizsgálat szerepe a koszorúér-analízisen túl. Aortabillentyű endocarditis ritka szövődménye – 
esetismertetés. Cardiologia Hungarica 2009; 39: A38 
Lénárd L, Várady E, Czopf L, Balla E, Göbölös L, Imre J, Hejjel L, Pintér Ö, Szabados S: Q-láz okozta 
aorta- és mitrális billentyű endocarditis. Cardiologia Hungarica 2009; 39: H10 
Várady E, Ruzsics B, Szukits S, Kónyi A, Szabados E, Simor T, Battyáni I: Malignus és nem malignus 
koszorúér anomáliák differenciálása 64 szeletes dual source CT készülékkel Cardiologia Hungarica 
2010; 40: G32 
Lévai A, Battyány I, Várady E: Kemoterápiás szerek okozta toxikus tüdőelváltozások. Magyar 
Radiológia 2010; 84 (2): 95. 
 
16 
 
Szukits S, Csete M, Várady E, Weninger C, Battyány I: Dóziscsökkentési lehetőségek a pulmonalis 
embolia CT-diagnosztikájában. Magyar Radiológia 2010; 84 (2): 107. 
Várady E, Ruzsics B, Szukits S, Hernádi G, Battyány I: Mellékleletek 64 szeletes DSCT-készülékkel 
végzett coronaria –CT-angiográfiás vizsgálatok során. Magyar Radiológia 2010; 84 (2): 115. 
Várady E, Ruzsics B, Szukits S, Kónyi A, Battyány I: Koszorúér-anomáliák kimutatása 64 szeletes dual 
source CT-készülékkel Magyar Radiológia 2010; 84 (2): 124. 
Lénárd L, Tornóczky T, Pintér Ö, Várady E, Meskó S, Bertalan A, Molnár FT, Szabados S: Ectopiás 
pancreas a mediastinumban Cardiologia Hungarica 2010;40: P14. 
Szabados S, Lénárd L, Farkasfalvi K, Simor T, Szukits S, Várady E, Ruzsics B: A szív CT prioritása (?) az 
aortadissectio diagnosisában és műtét megnevezésében – esettanulmány Cardiologia Hungarica 
2010;40: P22 
  
 
17 
 
 
Acknowledgements 
With gratitude I owe to many people who helped and supported me during my clinical researches.  
I have to thank to my supervisors: Professor Tamás Simor and István Battyáni MD, and to all my 
associates who I had been working together during the different projects: Eszter Fehér MD, Lajos 
Markó MD, Sándor Szukits MD, Balázs Gaszner MD, Zsófia Lenkey MD, Róbert Husznai MD, Ádám 
Németh MD, Judit Füller MD, Gábor Hild MD, Beáta Bódis MD, Dezső Dániel MD, Péter Rausch MD.  I 
was appreciated the professional job of the staff in the CT lab as well.  
Special thanks to my family: to my husband, László Péter Lénárd MD for his faithful support through 
the years and to my children, Álmos, Márton and Botond for the time I spent away. 
Last but not least many thanks to Professor Péter Bogner for the encouragement.   
 
 
 
 
